Skip to main content
BBIO logo

BBIO · BridgeBio Pharma, Inc. · Held by Funds

Track BBIO — free
$74.29 +0.02 (+0.03%) At close · Nov 6 Play latest call Q3 2026 earnings call transcript
Market Cap
$14.47B
Shares
194.80M
Volume · Nov 6 3.16M Avg daily vol (3M) 2.7M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of BBIO by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 15.01% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.88% 5,608,328
Index ETFs 12.13% 23,621,714
Active ETFs 0.66% 1,292,556
Active funds 16.17% 31,504,570
Unclassified 0.54% 1,049,626
All registered funds 32.38% 63,076,794
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding BBIO

479 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 479 positions
Key facts CIK 1743881 CUSIP 10806X102 13F (30d) 209 filings 184 filers Visit website Investor relations